ARTL
$0.41
Artelo Biosciences
$.00
.77%
ARTL
Earnings Whisper ®
N/A
2nd Quarter February 2022
Consensus:  ($0.06)
Revenue:  $0.00 Mil
Wednesday
Apr 13
8:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ARTL reports earnings?
Beat
Meet
Miss

Where is ARTL's stock price going from here?
Up
Flat
Down
Stock chart of ARTL
Analysts
Summary of analysts' recommendations for ARTL
Score
Grade
Pivots
Resistance
$0.45
$0.44
$0.42

$0.41

Support
$0.39
$0.38
$0.36
Tweet
Growth
Description
Artelo Biosciences Inc. is a biopharmaceutical company. It is engaged in development and commercialization of proprietary therapeutics targeting the endocannabinoid system. The company's product pipeline consists of ART27.13, ART12.11 and ART26.12 which are in clinical stage. Artelo Biosciences Inc. is based in La Jolla, CA.